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Abstract: 
Binding modalities of doxorubicin (DOX), a widely used antineoplastic anthracyline antibiotic with hemoglobin (Hb) have been 
studied. The protein and the ligand were prepared using CORINA and protonated with insight II. The best conformation was sought 
by employing GOLDV. Molecular modeling calculations showed that DOX binds Hb to a non-classical drug binding site. The alpha 
subunit of Hb has been assigned to posses the binding site for DOX with a binding affinity (Ka) = 16.98 x10
3 mol
-1. The interaction 
was found to be thermodynamically favorable (ΔG° = -66.23 KJmol
-1). The analysis of DOX binding site to Hb suggested that the 
types of interactions that contribute in this binding are hydrophobic contacts, hydrogen bonding and electrostatic interactions. 
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Background: 
It is well established that free molecules of drug can act at the 
target site. This is because free drugs are rapidly distributed into 
tissues, which facilitate direct binding to tissue proteins. The 
binding of drugs to plasma and tissue proteins is common. This 
is considered to be an important factor to determine the 
pharmacokinetics and pharmacodynamics of drugs. The 
formation of drug–protein adducts can cause cellular and tissue 
toxicity which may be either intrinsic or idiosyncratic in nature 
[1, 2]. Protein-drug interactions play an important role in a 
variety of biological processes and disease treatments. The 
studies on this aspect may provide information of the structural 
features of protein that may determine the therapeutic 
effectiveness of drugs, and become an important research in 
biomedicine. A high binding affinity for protein has been 
observed for drugs possessing acidic or strong electronegative 
functional groups [3], which can bind to more than one binding 
site with different specificity. It is worth mentioning that 
saturable binding of some ligands to protein induce alterations in 
the structure and function of protein. However, selective binding 
displayed by different ligands may result an allosteric effects, 
whereby, binding of ligand A at certain site causes a 
conformational change in the protein so that binding of ligand B 
at a different site is altered [4]. 
 
Hemoglobin (Hb) is the iron containing oxygen transport 
metallo-protein in the red blood cells which is also known for 
the transport of carbon dioxide and regulation of blood pH [5]. 
Each subunit of Hb is a globular protein with an embedded 
heme group. The protein tetramer comprises of two α- and two 
β-chains assembled to form symmetrical (αβ) dimers. In the 
center of each heme group is a Fe
2+. The Hb exists in 
functionally important two isomeric forms the R form 
(oxygen/ligand bound state) and the T form (Deoxy state) [6, 7], 
which helps in proper coordination between upload and release 
of oxygen.  
 
Doxorubicin (DOX) is an effective chemotherapeutic agent for 
the treatment of breast cancer, malignant lymphomas, soft tissue 
sarcoma and various neoplastic diseases. This anthracycline 
antibiotic has a water-soluble basic amino sugar, daunosamine, 
which is linked glycosidically to carbon 7 of a four-ringed water 
insoluble aglycone known as doxorubicinone. Aglycone is a 
substituted naphthacene quinone with a methoxy group at the 4-
position and a hydroxyl group plus a hydroxyacetyl group at 
carbon 9 [8]. DOX has been shown to oxidize Hb [9]  and 
produce superoxide in red cells [10]. This may result in 
haemolysis  [11]. Although it has been suggested DOX on 
reduction, reacts directly with oxy-Hb [12]. Its binding site has 
not yet reported. An array of in solution techniques are available 
to determine various binding attributes of drugs, which closely 
represents the physiological conditions, but unable to determine 
the location of binding sites. The computational modeling was 
used to identify the amino acids involved in binding site. 
Moreover, it can also predict various conformational states of 
bio-molecules such as the oxygen bound form of Hb as 
described in the present study. 
 
Methodology: 
Genetic algorithm 
Genetic algorithm (GA) is a computer program that mimics the 
process of evolution by manipulating a collection of data-
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solution (in terms of a possible ligand-receptor interaction) to 
the docking problem and may be assigned fitness score based on 
the relative merit of the solution. The GA utilizes a novel 
representation of the docking process. Each chromosome 
encodes an internal conformation and protein active site. This 
includes mapping of hydrogen-bonding sites in the ligand and 
protein. A least-square fitting process is employed to position 
the ligand within the active site of the protein in such a way that 
as many of the hydrogen bonds suggested by the mapping are 
formed upon decoding a chromosome. The fitness of a decoded 
chromosome is then a combination of number and strength of 
hydrogen bonds that are formed in this way in addition to the 
van der Waals energy of the bound complex.  
 
Preparation of the protein target and ligand 
Known crystal structures of oxy-Hemoglobin (Hb) (PDB Id: 
1HHO) was obtained from the Brookhaven Protein Data Bank. 
The two dimensional (2D) structure of DOX (Figure 1) was 
downloaded from Pubchem (pubchem.ncbi.nlm.nih.gov). 2D to 
3D conversion was done using CORINA [13]. Water molecules 
and ions were removed (including ordered water molecules) and 
hydrogen atoms were added at appropriate geometry. Groups 
within the protein were ionized as required at physiological pH. 
The structure of Hb was protonated using Insight II 
(www.accelrys.com). The genetic algorithm was implemented in 
GOLDv3.1.1 that was applied to calculate the possible 
conformations of the drug binding to protein. The genetic 
algorithm parameters used in the analysis include, population 
size 100, number of islands 5, niche size 2, selection pressure 
1.1, migrate 2; number of operators 100,000, mutate 95 and 
crossover 95. A maximum of 10 different conformations was 
considered for the drug during the docking process. The 
conformer with the lowest binding free energy was used for 
further analysis.  
 
Molecular docking simulations 
All the conformations were then evaluated by X-Score. RMSD 
values of the best scored conformations of these protein-ligand 
complexes were calculated. The binding energy of docked 
complexes was calculated using X-Score [14]. The scoring 
functions have all the necessary elements that correspond to the 
non-covalent interactions in a conventional force field, such as 
the van der Waals interaction and the electrostatic interaction. It 
also considers the hydrophobic effect and thus provides a better 
estimation of binding free energies. A special feature is that 
three different algorithms have been implemented to calculate 
the hydrophobic effect term and this result in three parallel 
scoring functions. All three scoring functions are calibrated 
through multivariate regression analysis of protein-ligand 
complexes and this reproduces the binding free energies of the 
entire complex. These three scoring functions are further 
combined into a consensus scoring function called X-Score. The 
residues that are making hydrogen bonding and hydrophobic 
interactions were calculated using Getneares, a tool available 
with DOCKv5.1.1 [15].  
Discussion: 
Hb drug binding 
The complementary applications of molecule modeling have 
been employed by computer methods to improve the 
understanding of the interaction of DOX and Hb. The best 
docking result is shown in Figure 2. As predicted from the 
docking procedure the DOX binding site is situated on the alpha 
subunit of Hb. The binding free energy (ΔG°) and the binding 
affinity (Ka) were found to be -66.23 KJmol
-1  and 16.98 x 
10
3mol
-1, respectively. Negative value of ΔG° shows that the 
binding reaction is thermodynamically favorable and the value 
of binding constant predicts high binding affinity between 
protein and drug.  
 
Binding site  
The amino acid residues involved in the binding of DOX to Hb 
were predicted and their respective molecular distances from the 
bound drug have been evaluated with the Getnears as presented 
in Table 1 (see supplementary material). The presented data 
revealed that His45 is the closest residue to be found in the 
vicinity (5 Å) of the drug molecule and Gly57 was found to be 
far away. The modeling study showed that DOX binds to Hb on 
the surface binding site. At this site, the conformation of ligand 
differs from that in aqueous solution, where the mean plane of 
the sugar is perpendicular to the dihydroxyanthraquinone plane. 
In view of the finding that glycosidic linkage (C(6a)–C(7)–
O(7)–C(1′)) has changed in DOX binding biomacromolecule 
[16], we can also predict the conformational change in Hb upon 
the binding of DOX molecule.  
 
Binding mode 
The validation of the binding mode as per the amino acid 
residue predicted to be part of the binding site is shown in 
Figure 2. The phenol ring of DOX is making hydrophobic 
interactions with Phe46, Ala53, Gly57. The interaction between 
DOX and Hb is not exclusively hydrophobic as there are several 
ionic and polar residues (His45, Gln54, Lys61, Lys90, and 
Arg197) in the proximity of the bound ligand (within 5 Å). 
These polar residues play an important role in stabilizing DOX 
via H-bonds and electrostatic interactions. Lys61 is in a suitable 
position involved in making H-bonds with the imino groups of 
the side chain. Basic amino acids like Arg197 and Lys90 in the 
vicinity of DOX are targets for interactions with negatively 
charged carbonyl oxygen functions of the 
dihydroxyanthraquinone moiety. The hydrogen-bonding or 
electrostatic interaction acts as an anchor and this helps to attain 
the 3D space position of DOX in its binding pocket. This 
facilitates the hydrophobic interaction of the 
dihydroxyanthraquinone rings with the side chain of Hb 
residues. The DOX is in close proximity to the heme ring and 
this imply the interference in the oxygen binding property of the 
protein. It has been shown that the interaction of DOX with Hb 
induced a significant increase (22%) in oxygen affinity as 
compared with Hb without drug [17]. 
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Figure 1: Two dimensional structure of doxorubicin downloaded from PubChem (pubchem.ncbi.nlm.nih.gov). 
 
 
Figure 2: Doxorubicin docked onto hemoglobin zoomed to show the amino acid residues involved in the binding site. DOX, 
represented in stick (light blue) and hemoglobin, represented in surface colored in olive yellow. The heme ring depicted as brown 
color stick structure with bound oxygen (green). The image was prepared using Pymol (pymol.sourceforge.net). Bioinformation by Biomedical Informatics Publishing Group                                     open access 
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Conclusion: 
The binding property of DOX with Hb has been studied using 
molecular surface analysis. The DOX binding properties of Hb 
was mapped using molecular docking techniques. Docking 
calculations found DOX to be located at the superficial site 
within the alpha subunit of Hb. The model showed the 
microenvironment of DOX to be rich in polar (basic) amino acid 
residues able to stabilize the ligand. This work provides 
comprehensive insight and understanding for the molecular 
interaction of DOX with Hb in vivo. 
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Supplementary material 
 
Protein atom  Ligand atom  Distance (Å) 
HIS 45 NE2  7  O7  DOX  2.81 
PHE 46 CZ  9  O9  DOX  4.30 
ALA 53 O  11  O11 DOX  4.19 
GLN 54 CG  38  C26 DOX  3.43 
GLY 57 CA  11  O11 DOX  4.41 
LYS 61 NZ  5  O5  DOX  3.05 
LYS 90 NZ  30  C18 DOX  4.36 
HEM 1 O1D  8  O8  DOX  2.66 
Table 1: Molecular docking analysis of DOX binding to Hb. Prediction of atoms involved and estimated distances between protein 
and ligand atoms is given. 
 
 